Predictive Biomarkers for the Efficacy of Conversion Therapy in Gastric Cancer are Expected to be a Prominent Research Focus

Ann Surg Oncol. 2024 Dec 16. doi: 10.1245/s10434-024-16710-x. Online ahead of print.
No abstract available

Publication types

  • Letter